23 May 2013
Keywords: fda, rejects, eisai, fospropofol, japanese, drugmaker, received
Article | 04 August 2008
Japanese drugmaker Eisai has received a "not approvable" letter from the US Food and Drug Administration, delaying the potential approval ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 August 2008
22 May 2013
© 2013 thepharmaletter.com